β2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation

International Journal of Toxicology

Volumn 25, Issue 6, 2006, Pages 443-449

  Kaymak, Çetin ^a   Kocabaş, Neslihan Aygün ^b   Durmaz, Emre ^b   Öztuna, Derya ^c  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

2 Adrenoceptor; Cardiovascular Phenotype; Laryngoscopy; Pharmacogenetics; Tracheal Intubation

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR; FENTANYL; GLUTAMIC ACID; GLUTAMINE; GLYCINE; THIOPENTAL; VECURONIUM; BETA 2 ADRENERGIC RECEPTOR;

ADULT; ALLELE; ALLELE SPECIFIC POLYMERASE CHAIN REACTION; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CODON; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG METABOLISM; ENDOTRACHEAL INTUBATION; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMODYNAMICS; HOMOZYGOTE; HUMAN; LARYNGOSCOPE; LARYNGOSCOPY; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; VASODILATATION; ADOLESCENT; AGED; BLOOD PRESSURE; GENETICS; HEART RATE; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; FEMALE; GENOTYPE; HEART RATE; HUMANS; INTUBATION, INTRATRACHEAL; LARYNGOSCOPY; MALE; MIDDLE AGED; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 33845358698     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810600959519     Document Type: Article

References (40)

1. Anderson, J. L., J. F. Carlquist, B. D. Horne, and J. B. Muhlestein. 2003. Cardiovascular pharmacogenomics: Current status, future prospects. J. Cardiovasc. Pharmacol. Ther. 8:71-83.
2. Aynacioǧlu, A. S., I. Cascorbi, and R. Gungor. 1999. Population frequency, mutation linkage and analytical methodology for the Arg16Gly, Gln27Glu and Thr164Ile polymorphisms in the beta2-adrenergic receptor among Turks. Br. J. Clin. Pharmacol. 48:761-764.
3. Busjahn, A., G. H. Li, H. D. Faulhaber, M. Rosenthal, A. Becker, E. Jeschke, H. Schuster, B. Timmermann, M. R. Hoehe, and F. C. Luft. 2000. β2 Adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 35:555-560.
4. Candy, G., N. Samani, G. Norton, A. Woodiwiss, I. Radevski, A. Wheatley, J. Cockcroft, and I. P. Hall. 2000. Association analysis of β2 adrenoceptor polymorphisms with hypertension in a black African population. J. Hypertens. 18:167-172.
5. Castellano, M., F. Rossi, M. Giacche, C. Perani, F. Rivadassi, M. L. Muiesan, M. Salvetti, M. Beschi, D. Rizzoni, and E. Agabiti-Rosei. 2003. Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 41:361-367.
6. Derbyshire, D. R., A. Chmielewski, D. Fell, M. Vater, K. Achola, and G. Smith. 1983. Plasma catecholamine responses to tracheal intubation. Br. J. Anaesth. 55:855-859.
7. Donati, F. 2003. Tracheal intubation: unconsciousness, analgesia and muscle relaxation. Can. J. Anaesth. 50:99-103.
8. Edwards, N. D., A. M. Alford, P. M. Dobson, J. E. Peacock, and C. S. Reilly. 1994. Myocardial ischaemia during tracheal intubation and extubation. Br. J. Anaesth. 73:537-539.
9. Eisenach, J. H., A. M. McGuire, R. M. Schwingler, S. T. Turner, and M. J. Joyner. 2004. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol. Genomics 16:323-328.
10. Evans, W. E., and H. L. N. McLeod. 2003. Pharmacogenomics: Drug disposition, drug targets, and side effects. N. Engl. J. Med. 348:538-549.
11. Fox, E., G. S. Sklar, C. R. Hill, Villanueva, and B. D. King. 1977. Complications related to the pressor response to endotracheal intubation. Anesthesiology 47:524-525.
12. Galley, H. F., A. Mahdy, and D. A. Lowes. 2005. Pharmacogenetics and anesthesiologists. Pharmacogenomics 6:849-856.
13. Gratze, G., J. Fortin, R. Labugger, A. Binder, P. Kotanko, B. Timmermann, F. C. Luft, M. R. Hoehe, and F. Skrabal. 1999. β2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilatation in young adult Caucasians. Hypertension 33:1425-1430.
14. Gren, S. A., J. Turki, M. Innis, and S. B. Liggett. 1994. Amino terminal polymorphisms of the human β2 adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414-9419.
15. Hall, I. P. 1996. β2 Adrenoceptor polymorphisms: Are they clinically important? Thorax 51:351-353.
16. Hoit, B. D., D. P. Suresh, L. Craft, R. A. Walsh, and S. B. Liggett. 2000. β2-Adrenergic receptor polymorphisms amino acid 16 differentially influences agonist-stimulated blood pressure and peripheral blood flow in normal individuals Am. Heart J. 139:537-542.
17. Hung, O. 2001. Understanding hemodynamic responses to tracheal intubation. Can. J. Anaesth. 48:723-726.
18. Iohom, G., D. Fitzgerald, and A. J. Cunningham. 2004. Principles of pharmacogenetics - implications for the anaesthesist. Br. J. Anaesth. 93:440-450.
19. Johnson, M. 1998. The beta-adrenoceptor. Am. J. Respir. Crit. Care Med. 158:146-153.
20. Kayhan, Z., D. Aldemir, H. Mutlu, and E. Ogus. 2005. Which is responsible for the haemodynamic response due to laryngosscopy and endotracheal intubation? Catecholamines, vasopressin or angiotensin? Eur. J. Anaesthesiol. 22:780-785.
21. Kim, N. S., I. O. Lee, M. K. Lee, S. H. Lim, Y. S. Choi, and M. H. Kong. 2002. The effects of β2 adrenoceptor gene polymorphisms on pressor response during laryngoscopy and tracheal intubation. Anesthesia 57:227-232.
22. Kobilka, B. K., R. A. Dixon, T. Frielle, H. G. Dohlman, M. A. Bolanowski, I. S. Sigal, T. L. Yabg-Feng, U. Francke, M. G. Caron, and R. J. Lefkowitz. 1987. cDNA for human beta 2-adrenergic receptor: A protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 84:46-50.
23. Leineweber, K, R. Büscher, H. Bruck, and O. E. Brode. 2004. β-Adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol. 369:1-22.
24. Li, G. H., H. D. Faulhaber, M. Rosenthal, H. Schuster, J. Jordan, B. Timmermann, M. R. Hoehe, F. C. Luft, and A. Busjahn. 2001. β2 Adrenergic receptor gene variations and blood pressure under stress in normal twins. Psychophysiology 38:485-489.
25. Liggett, S. B. 1995. Genetics of beta 2-adrenergic receptor variants in asthma. Clin. Exp. Allergy 25:89-94.
26. Littlejohn, M. D., D. R. Taylor, A. L. Miller, and M. A. Kennedy. 2002. Determination of β2-adrenergic receptor (ADRB2) haplotypes by a multiplexed polymerase chain reaction assay. Hum. Mutat. 20:479.
27. Low, J. M., J. T. Harvey, C. Prys-Roberts, and J. Dagnino. 1986. Studies of anesthesia in relation to hypertension. Br. J. Anaesth. 58:471-477.
28. Martinez, F. D., P. E. Graves, M. Baldini, S. Solomon, and R. Erickson. 1997. Association between genetic polymorphisms of the β2 adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100:3184-3188.
29. McCoy, E. P., R. K. Mirakhur, and B. V. McCloskey. 1995. A comparison of the stress response to laryngoscopy. The Macintosh versus the McCoy blade. Anesthesia 50:943-946.
30. McLeod, H. L., and W. E. Evans. 2001. Pharmacogenomics: Unlocking to human genome for better drug treatment. Annu. Rev. Pharmacol. Toxicol. 41:101-121.
31. Meyer, J. M., and G. S. Ginsburg. 2002. The path to personalized medicine. Curr. Opin. Chem. Biol 6:434-438.
32. Nickander, K. K., P. J. Carlson, R. A. Urrutia, M. Camilleri, and A. Low. 2005. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci. 120:97-103.
33. Rosmond, R., O. Ukkola, M. Chagnon, C. Bouchard, and P. Bjorntorp. 2000. Polymorphisms of the β2-adrenergic receptor gene in relation to cardiovascular risk factors in men. J. Intern. Med. 248:239-244.
34. Shribman, A. J., G. Smith, and A. J. Achola. 1987. Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br. J. Anaesth. 59:295-299.
35. Snapir, A., J. Koskenvuo, J. Toikka, M. Orho-Melander, S. Hinkkas, M. Saraste, J. Hartiala, and M. Scheinin. 2003. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline. Clin. Sci. (Lond) 104:509-520.
36. Snieder, H., Y. Dong, P. Barbeau, G. A. Harshfield, C. Dalageogou, H. Zhu, N. D. Carter, and F. A. Treiber. 2002. β2-Adrenonergic receptor gene and resting hemodynamics in European and African American youth. Am. J. Hypertens. 15:973-979.
37. Stone, D. J., and T. J. Gal. 2000. Airway management. In Anesthesia, ed. R. D. Miller, 1444-1446. New York: Churchill Livingstone.
38. Takita, K., Y. Morimoto, and O. Kemmotsu. 2001. Tracheal lidocaine attenuates the cardiovascular response to endotracheal intubation. Can. J. Anaesth. 48:732-736.
39. Timmermann, B., R. Mo, F. C. Luft, E. Gerdts, A. Busjahn, P. Omvik, G. H. Li, H. Schuster, T. F. Wienker, M. R. Hoehe, and P. Lund-Johansen. 1998. β2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int. 53:1455-1460.
40. Viby-Mogensen, J., J. Engbaek, L. I. Eriksson, L. Gramstad, E. Jensen, F. S. Jensen, Z. Koscielniak-Nilsen, L. T. Skovgaard, and D. Ostergaard. 1996. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol. Scand. 40:59-74.